The Clorox Company
CLX · NYSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.10 | 0.69 | -1.95 | -1.12 |
| FCF Yield | 5.13% | 2.90% | 4.73% | 3.08% |
| EV / EBITDA | 12.55 | 26.32 | 38.50 | 21.85 |
| Quality | ||||
| ROIC | 24.14% | 15.76% | 13.43% | 11.52% |
| Gross Margin | 44.96% | 42.65% | 38.86% | 35.05% |
| Cash Conversion Ratio | 1.19 | 2.38 | 7.19 | 1.67 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.30% | -0.07% | 0.22% | 1.88% |
| Free Cash Flow Growth | 57.56% | -48.06% | 73.83% | -43.39% |
| Safety | ||||
| Net Debt / EBITDA | 1.94 | 3.67 | 4.43 | 3.15 |
| Interest Coverage | 11.67 | 8.89 | 8.03 | 7.18 |
| Efficiency | ||||
| Inventory Turnover | 7.48 | 6.39 | 6.49 | 6.11 |
| Cash Conversion Cycle | 12.78 | 7.68 | 7.73 | 18.76 |